Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong · Delayed Price · Currency is HKD 1.195
-0.030 (-2.45%)
Oct 2, 2026, 3:54 PM HKT
Venus Medtech (Hangzhou) Market Cap
Venus Medtech (Hangzhou) has a market cap or net worth of 523.29 million as of October 2, 2026. Its market cap has decreased by -64.11% in one year.
Market Cap
523.29M
Enterprise Value
674.98M
Revenue
294.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
ChartMarket Cap Chart
Since December 10, 2019, Venus Medtech (Hangzhou)'s market cap has decreased from 16.91B to 523.29M, a decrease of -96.90%. That is a compound annual growth rate of -39.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 523.29M | -49.79% |
| Dec 31, 2025 | 1.04B | -83.31% |
| Dec 30, 2022 | 6.24B | -51.82% |
| Dec 31, 2021 | 12.96B | -61.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acotec Scientific Holdings | 1.98B |
| MicroPort CardioFlow Medtech | 1.63B |
| Sisram Medical | 934.34M |
| Cryofocus Medtech (Shanghai) | 741.46M |
| Gaush Meditech | 645.64M |
| Vincent Medical Holdings | 435.67M |
| Broncus Holding | 387.40M |
| Austar Lifesciences | 369.06M |